|
US5480772A
(en)
|
1993-02-03 |
1996-01-02 |
Brandeis University |
In vitro activation of a nucleus
|
|
GB9517779D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
|
US7332648B2
(en)
|
1995-08-31 |
2008-02-19 |
Roslin Institute |
Unactivated oocytes in nuclear transfer to produce cultured inner cell mass cells and ungulates
|
|
GB9517780D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
|
US6077697A
(en)
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
|
US6025155A
(en)
*
|
1996-04-10 |
2000-02-15 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
|
US7696404B2
(en)
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
|
CA2267220A1
(en)
|
1996-10-11 |
1998-04-23 |
The Texas A & M University System |
Methods for the generation of primordial germ cells and transgenic animal species
|
|
US5945577A
(en)
*
|
1997-01-10 |
1999-08-31 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloning using donor nuclei from proliferating somatic cells
|
|
US6215041B1
(en)
*
|
1997-01-10 |
2001-04-10 |
University Of Mmassachusetts |
Cloning using donor nuclei from a non-quiesecent somatic cells
|
|
AU8154398A
(en)
*
|
1997-01-10 |
1999-01-25 |
University Of Massachusetts |
Cloning using donor nuclei from non-serum starved, differentiated cells
|
|
US20090092588A1
(en)
*
|
1997-01-10 |
2009-04-09 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
|
|
US6235969B1
(en)
*
|
1997-01-10 |
2001-05-22 |
University Of Massachusetts |
Cloning pigs using donor nuclei from non-quiescent differentiated cells
|
|
GB9703550D0
(en)
*
|
1997-02-20 |
1997-04-09 |
Ppl Therapeutics Scotland Ltd |
Cell mediated transgenesis
|
|
US6011197A
(en)
|
1997-03-06 |
2000-01-04 |
Infigen, Inc. |
Method of cloning bovines using reprogrammed non-embryonic bovine cells
|
|
AU744445B2
(en)
|
1997-04-24 |
2002-02-21 |
University Of Washington |
Targeted gene modification by parvoviral vectors
|
|
WO1998057984A2
(en)
|
1997-06-19 |
1998-12-23 |
The General Hospital Corporation |
Torsin, torsin genes, and methods of use
|
|
US6921814B2
(en)
|
1997-06-19 |
2005-07-26 |
The General Hospital Corporation |
Torsin, torsin-related genes and methods of detecting neuronal disease
|
|
AU8587598A
(en)
*
|
1997-07-26 |
1999-02-16 |
Wisconsin Alumni Research Foundation |
Trans-species nuclear transfer
|
|
CA2300972A1
(en)
*
|
1997-08-22 |
1999-03-04 |
Biotechnology And Biological Sciences Research Council |
Use of mariner transposan in the production of transgenic animals
|
|
EP1009818A1
(en)
*
|
1997-09-02 |
2000-06-21 |
Cancer Research Campaign Technology Limited |
A cell-free replication system and uses thereof
|
|
WO1999021415A1
(en)
*
|
1997-10-28 |
1999-05-06 |
Stem Cell Sciences Pty. Ltd. |
Nuclear transfer for production of transgenic animal embryo
|
|
DE59812083D1
(de)
|
1998-01-16 |
2004-11-11 |
Agrobiogen Gmbh |
Effizienter kerntransfer mit fetalen fibroblasten
|
|
US6331659B1
(en)
*
|
1998-01-21 |
2001-12-18 |
University Of Hawaii |
Cumulus cells as nuclear donors
|
|
WO1999046982A1
(en)
*
|
1998-03-16 |
1999-09-23 |
Relag Pty Ltd |
Porcine nuclear transfer
|
|
AUPP294898A0
(en)
*
|
1998-04-15 |
1998-05-07 |
Monash University |
Method of nuclear transfer
|
|
GB9808325D0
(en)
*
|
1998-04-20 |
1998-06-17 |
Ltr Ciz Di Associazione Italia |
Source of nuclei for nuclear transfer
|
|
GB9809178D0
(en)
*
|
1998-04-29 |
1998-07-01 |
Univ Edinburgh |
Nuclear reprogramming of somatic cells
|
|
AU6218899A
(en)
|
1998-10-12 |
2000-05-01 |
Geron Bio-Med Limited |
Porcine oocytes with improved developmental competence
|
|
US6580017B1
(en)
|
1998-11-02 |
2003-06-17 |
Genzyme Transgenics Corporation |
Methods of reconstructed goat embryo transfer
|
|
US6781030B1
(en)
|
1998-11-02 |
2004-08-24 |
Trustee Of Tufts College, Ballou Hall |
Methods for cloning mammals using telophase oocytes
|
|
AU2003204830B2
(en)
*
|
1998-11-02 |
2007-08-30 |
Gtc Biotherapeutics, Inc. |
Transgenic and cloned mammals
|
|
EP1375654A3
(en)
*
|
1998-11-02 |
2008-01-16 |
GTC Biotherapeutics, Inc. |
Transgenic and cloned mammals
|
|
JP4523165B2
(ja)
*
|
1998-11-02 |
2010-08-11 |
トラスティーズ オブ タフツ カレッジ |
トランスジェニックおよびクローン哺乳動物
|
|
ATE427653T1
(de)
|
1998-11-19 |
2009-04-15 |
Pharming Intellectual Pty Bv |
Stabilisierung der milch transgener tieren
|
|
US6700037B2
(en)
|
1998-11-24 |
2004-03-02 |
Infigen, Inc. |
Method of cloning porcine animals
|
|
US6258998B1
(en)
|
1998-11-24 |
2001-07-10 |
Infigen, Inc. |
Method of cloning porcine animals
|
|
EP1141265B1
(en)
*
|
1999-01-13 |
2008-09-03 |
Revivicor, Inc. |
Double nuclear transfer method and results thereof
|
|
GB9903804D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-2
|
|
GB9903805D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-1
|
|
WO2000050443A2
(en)
|
1999-02-26 |
2000-08-31 |
Millennium Pharmaceutcals, Inc. |
Secreted proteins and uses thereof
|
|
ATE452973T1
(de)
|
1999-03-04 |
2010-01-15 |
Revivicor Inc |
Genetische veränderung von somatischen zellen und deren verwendungen
|
|
US20020012660A1
(en)
*
|
1999-03-04 |
2002-01-31 |
Alan Colman |
Method of preparing a somatic cells for nuclear transfer
|
|
BR0010588A
(pt)
*
|
1999-04-28 |
2003-07-22 |
Univ Montreal |
Oócitos enucleados de telofase para transferência nuclear
|
|
IL146829A0
(en)
*
|
1999-06-04 |
2002-07-25 |
Istituto Zootecnico E Caseario |
Process for reconstructing a non-human animal embryo by nuclear transfer and preparing the animal therefrom, and embryos and animal obtained thereby
|
|
EP1194570A1
(en)
|
1999-06-23 |
2002-04-10 |
PPL Therapeutics (Scotland) Limited |
Fusion proteins incorporating lysozyme
|
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
|
CN1304445A
(zh)
*
|
1999-06-30 |
2001-07-18 |
黄禹锡 |
一种通过用种间核转移技术生产克隆虎的方法
|
|
CA2334953A1
(en)
*
|
1999-06-30 |
2001-01-04 |
Woo-Suk Hwang |
Method for producing human cloned embryos by employing inter-species nuclear transplantation technique
|
|
WO2001000650A1
(en)
*
|
1999-06-30 |
2001-01-04 |
Advanced Cell Technology, Inc. |
Cytoplasmic transfer to de-differentiate recipient cells
|
|
JP3652308B2
(ja)
*
|
1999-06-30 |
2005-05-25 |
ソウル ナショナル ユニバーシティー インダストリー ファウンデーション |
クローンウシの生産方法
|
|
HU228477B1
(en)
|
1999-08-23 |
2013-03-28 |
Dana Farber Cancer Inst Inc |
Pd-1, a receptor for b7-4, and uses therefor
|
|
EP2275559A3
(en)
|
1999-09-28 |
2011-03-23 |
Shire Human Genetic Therapies, Inc. |
Optimized messenger RNA
|
|
WO2002064799A2
(en)
|
1999-09-28 |
2002-08-22 |
Transkaryotic Therapies, Inc. |
Optimized messenger rna
|
|
CN1402781A
(zh)
*
|
1999-09-30 |
2003-03-12 |
根茨美转基因公司 |
克隆和转基因哺乳动物的生产方法
|
|
US7074983B2
(en)
*
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
|
US7414170B2
(en)
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
|
KR100417566B1
(ko)
*
|
1999-11-19 |
2004-02-05 |
한국생명공학연구원 |
체세포 핵치환 복제수정란의 대량생산방법
|
|
WO2001035735A1
(en)
*
|
1999-11-19 |
2001-05-25 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
|
US6635802B1
(en)
*
|
2000-01-10 |
2003-10-21 |
The Texas A&M University System |
Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
|
|
GB0001401D0
(en)
*
|
2000-01-22 |
2000-03-08 |
Univ Edinburgh |
Methods for amplifying genetic material and use thereof
|
|
DK1356031T3
(da)
|
2000-03-15 |
2011-10-31 |
Univ Georgia |
Effektiv kerneomprogrammering hos pattedyr
|
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
|
GB2360522A
(en)
|
2000-03-24 |
2001-09-26 |
Geron Corp |
A strategy for maintaining pregnancy
|
|
WO2001088096A2
(en)
*
|
2000-05-15 |
2001-11-22 |
Geron Corporation |
Ovine tissue for xenotransplantation
|
|
AU2001275346A1
(en)
|
2000-06-05 |
2001-12-17 |
General Hospital Corporation |
Compositions, kits, and methods for identification and modulation of type i diabetes
|
|
CA2414331C
(en)
|
2000-06-28 |
2011-11-29 |
Genetics Institute, Llc. |
Pd-l2 molecules: novel pd-1 ligands and uses therefor
|
|
AU2001278204A1
(en)
*
|
2000-08-01 |
2002-02-13 |
Xy Genetics, Llc |
Methods of selecting and cloning animals
|
|
MXPA03001915A
(es)
|
2000-08-03 |
2004-09-10 |
Therapeutic Human Polyclonals |
Produccion de anticuerpos humanizados en animales transgenicos.
|
|
AU2001284948A1
(en)
|
2000-08-15 |
2002-02-25 |
Board Of Trustees Of The University Of Illinois |
Animals expressing exogenous igf-i in their milk
|
|
WO2002019811A2
(en)
*
|
2000-09-06 |
2002-03-14 |
Nexia Biotechnologies, Inc. |
Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage
|
|
FR2814642B1
(fr)
|
2000-10-03 |
2005-07-01 |
Ass Pour Le Dev De La Rech En |
Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
|
|
US8105825B2
(en)
*
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
|
US20040029825A1
(en)
*
|
2001-10-03 |
2004-02-12 |
Davies Christopher J |
Methods of minimizing immunological rejection of a nuclear transfer fetus
|
|
AU2002236503C1
(en)
|
2000-11-28 |
2008-11-13 |
Wyeth |
Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
|
AU2002241524A1
(en)
|
2000-11-28 |
2002-06-11 |
Wyeth |
Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
|
US7491534B2
(en)
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
|
AU2002232858B2
(en)
|
2000-12-22 |
2007-01-11 |
Sab, Llc |
Methods for cloning mammals using reprogrammed donor chromatin or donor cells
|
|
EP1217071B1
(en)
|
2000-12-22 |
2010-04-28 |
Institut National De La Recherche Agronomique |
Position-independent and tissue specific expression of a transgene in milk of transgenic animals
|
|
US20020142397A1
(en)
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
|
EP1860199B1
(en)
|
2001-01-12 |
2014-03-05 |
Exelixis, Inc. |
Modulating insulin receptor signaling
|
|
EP1361789A2
(en)
|
2001-01-30 |
2003-11-19 |
Rebholtz, Amy K. |
Method for embryo transfer after impregnation of the recipient female
|
|
WO2002062131A2
(en)
*
|
2001-02-02 |
2002-08-15 |
Infigen, Inc. |
Method of cloning transgenic mammalian animals using pseudonuclei
|
|
WO2002066614A2
(en)
*
|
2001-02-20 |
2002-08-29 |
Rheogene Holdings, Inc. |
Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
|
CA2438832A1
(en)
|
2001-02-23 |
2002-09-06 |
Elan Pharmaceuticals, Inc. |
Transgenic knockouts of bace-1
|
|
JP2002262716A
(ja)
|
2001-03-07 |
2002-09-17 |
National Agricultural Research Organization |
株化細胞を用いて家畜個体を作出する方法
|
|
AU2002258477A1
(en)
*
|
2001-03-08 |
2002-09-24 |
Advanced Cell Technology, Inc. |
Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
|
|
AUPR363701A0
(en)
|
2001-03-09 |
2001-04-05 |
Garelag Pty Ltd |
Method for the production of nuclear transfer embryos
|
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
|
AU2002242854A1
(en)
*
|
2001-03-21 |
2002-10-03 |
Geron Corporation |
Use of telomerase reverse transcriptase to create homozygous knockout animals
|
|
US7126039B2
(en)
*
|
2001-03-21 |
2006-10-24 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
|
US20030027330A1
(en)
*
|
2001-04-02 |
2003-02-06 |
Robert Lanza |
Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
|
|
CA2442066C
(en)
|
2001-04-02 |
2005-11-01 |
Wyeth |
Pd-1, a receptor for b7-4, and uses therefor
|
|
IL158380A0
(en)
|
2001-04-16 |
2004-05-12 |
Wyeth Corp |
Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
|
|
US20030092174A1
(en)
*
|
2001-05-14 |
2003-05-15 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
|
US20030153044A1
(en)
*
|
2001-05-14 |
2003-08-14 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
|
US20030101469A1
(en)
*
|
2001-07-09 |
2003-05-29 |
Kenneth Bondioli |
Cloned non-human mammals from contact inhibited donor cells
|
|
CA2921821A1
(en)
|
2001-07-12 |
2003-01-23 |
University Of Massachusetts |
In vivo production of small interfering rnas that mediate gene silencing
|
|
EP1900815B1
(en)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In vivo production of small interfering RNAs that mediate gene silencing
|
|
AU2002326483A1
(en)
*
|
2001-07-31 |
2003-02-17 |
Simon Eric Aspland |
Genetically modified cows having reduced susceptibility to mad cow disease
|
|
US20030211603A1
(en)
*
|
2001-08-14 |
2003-11-13 |
Earp David J. |
Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
|
|
WO2003042362A2
(en)
|
2001-11-09 |
2003-05-22 |
Dana-Farber Cancer Institute, Inc. |
PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
|
|
US20030134422A1
(en)
*
|
2002-01-16 |
2003-07-17 |
Sayre Chauncey Bigelow |
Stem cell maturation for all tissue lines
|
|
US20050090004A1
(en)
*
|
2003-01-16 |
2005-04-28 |
Sayre Chauncey B. |
Stem cell maturation for all tissue lines
|
|
US20050170506A1
(en)
*
|
2002-01-16 |
2005-08-04 |
Primegen Biotech Llc |
Therapeutic reprogramming, hybrid stem cells and maturation
|
|
JP4968498B2
(ja)
|
2002-01-23 |
2012-07-04 |
ユニバーシティ オブ ユタ リサーチ ファウンデーション |
ジンクフィンガーヌクレアーゼを用いる、標的化された染色体変異誘発
|
|
KR100502695B1
(ko)
*
|
2002-02-28 |
2005-07-25 |
한국생명공학연구원 |
형질전환 효율이 향상된 복제수정란의 대량 생산 방법
|
|
AU2003218382B2
(en)
*
|
2002-03-21 |
2007-12-13 |
Sangamo Therapeutics, Inc. |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
|
GB0207299D0
(en)
*
|
2002-03-28 |
2002-05-08 |
Franks Christopher R |
Stem cell therapy
|
|
CN1650003A
(zh)
*
|
2002-04-01 |
2005-08-03 |
Gtc生物治疗学公司 |
选择用于哺乳动物种中核转移的细胞系的方法
|
|
US20030207448A1
(en)
*
|
2002-05-06 |
2003-11-06 |
Revera Gregory Henry |
Methodologies for the creation of pluripotent or multipotent human stem cells without creating or destroying a human embryo
|
|
GB0211904D0
(en)
*
|
2002-05-23 |
2002-07-03 |
Medical Res Council |
Nuclear transfer
|
|
WO2003104423A2
(en)
*
|
2002-06-11 |
2003-12-18 |
Roy Ogle |
Meningeal-derived stem cells
|
|
US7612250B2
(en)
|
2002-07-29 |
2009-11-03 |
Trustees Of Tufts College |
Nuclear transfer embryo formation method
|
|
CN102220423A
(zh)
|
2002-08-20 |
2011-10-19 |
千年药品公司 |
用于鉴定,评估,预防和治疗子宫颈癌的组合物,试剂盒及方法
|
|
EP2806025B1
(en)
*
|
2002-09-05 |
2019-04-03 |
California Institute of Technology |
Use of zinc finger nucleases to stimulate gene targeting
|
|
WO2004032877A2
(en)
|
2002-10-10 |
2004-04-22 |
Wyeth |
Compositions, organisms and methodologies employing a novel human kinase
|
|
US20040077077A1
(en)
*
|
2002-10-18 |
2004-04-22 |
Xiangzhong Yang |
Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same
|
|
EP1554385A2
(en)
|
2002-10-24 |
2005-07-20 |
Wyeth |
Calcineurin-like human phoshphoesterase
|
|
MXPA05004870A
(es)
|
2002-11-08 |
2005-11-04 |
Hematech Llc |
Ungulados transgenicos que tienen actividad reducida de la proteina prion y sus usos.
|
|
JP2006514554A
(ja)
|
2002-11-21 |
2006-05-11 |
ワイス |
腎細胞癌および他の固形腫瘍の診断法
|
|
WO2004050831A2
(en)
|
2002-11-27 |
2004-06-17 |
Wyeth |
Compositions, organisms and methodologies employing a novel human kinase
|
|
EP1578192A4
(en)
*
|
2002-12-10 |
2006-03-29 |
Gtc Biotherapeutics Inc |
METHOD AND SYSTEM FOR USING APPROPRIATED CORE TRANSFEREMBRYOES AS CELL DISPENSERS FOR AN ADDITIONAL NUCLEAR TRANSFER
|
|
JP5479663B2
(ja)
|
2002-12-20 |
2014-04-23 |
セレラ コーポレーション |
心筋梗塞に関連する遺伝的多型、その検出方法および使用
|
|
EP1581812B1
(en)
|
2003-01-06 |
2008-07-16 |
Wyeth |
Compositions and methods for diagnosing and treating colon cancers
|
|
FR2855183B1
(fr)
|
2003-05-23 |
2005-08-12 |
Agronomique Inst Nat Rech |
Procede de clonage du rat par transfert nucleaire
|
|
EP1633767B1
(en)
|
2003-06-02 |
2018-11-21 |
University of Massachusetts |
Methods and compositions for controlling efficacy of rna silencing
|
|
US8309704B2
(en)
|
2003-06-02 |
2012-11-13 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of RNAi
|
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US8409861B2
(en)
*
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
|
US20120196370A1
(en)
|
2010-12-03 |
2012-08-02 |
Fyodor Urnov |
Methods and compositions for targeted genomic deletion
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
WO2005017119A2
(en)
|
2003-08-14 |
2005-02-24 |
Exelixis, Inc. |
Ups as modifiers of the beta catenin pathway and methods of use
|
|
US7799518B2
(en)
|
2003-10-07 |
2010-09-21 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
EP1681988B1
(en)
|
2003-11-12 |
2015-04-08 |
The Children's Hospital Medical Center |
Method for diagnosis and treatment of pulmonary disorders
|
|
EP2405023B1
(en)
|
2003-11-26 |
2014-01-08 |
Celera Corporation |
Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods of Detection and Uses Thereof
|
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
NZ550106A
(en)
|
2004-04-22 |
2009-06-26 |
Kyowa Hakko Kirin Co Ltd |
Transgenic animals and uses thereof
|
|
US7820380B2
(en)
|
2004-05-07 |
2010-10-26 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis
|
|
JP2006081542A
(ja)
*
|
2004-08-18 |
2006-03-30 |
Institute Of Physical & Chemical Research |
クローン哺乳動物の作成方法
|
|
EP1812041A2
(en)
|
2004-10-22 |
2007-08-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating pgc-1 to treat lipid-related diseases and disorders
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
CN1274829C
(zh)
|
2004-12-10 |
2006-09-13 |
四川大学华西医院 |
抗eb病毒所致肿瘤多肽及其应用与制备方法
|
|
WO2006099365A2
(en)
|
2005-03-11 |
2006-09-21 |
Applera Corporation |
Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
|
|
US20060286666A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Kang Ji Y |
Methods and apparatuses for culturing stem cell using biomaterial shell
|
|
WO2007052096A2
(en)
*
|
2005-06-29 |
2007-05-10 |
Cameron Malcolm Lang Clokie |
Production of bone morphogenic proteins (bmps) in transgenic mammals
|
|
KR100733012B1
(ko)
|
2005-07-26 |
2007-06-28 |
재단법인서울대학교산학협력재단 |
복제된 개과 동물 및 이의 생산 방법
|
|
EP1924686A4
(en)
|
2005-08-09 |
2009-11-11 |
Revivicor Inc |
TRANSGENIC NAILS EXPRESSING CTLA4-IG AND USES THEREOF
|
|
WO2007030820A2
(en)
|
2005-09-09 |
2007-03-15 |
The Johns Hopkins University |
Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists
|
|
JP2009508596A
(ja)
|
2005-09-19 |
2009-03-05 |
ヒストジェニックス コーポレイション |
細胞支持基材及びその調製方法
|
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
|
US7695911B2
(en)
|
2005-10-26 |
2010-04-13 |
Celera Corporation |
Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
|
|
US8173860B2
(en)
|
2006-04-21 |
2012-05-08 |
Gtc Biotherapeutics, Inc. |
Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion
|
|
WO2008027986A2
(en)
|
2006-09-01 |
2008-03-06 |
Therapeutic Human Polyclonals, Inc. |
Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
|
|
US7993833B2
(en)
|
2006-09-11 |
2011-08-09 |
Celera Corporation |
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
|
|
EP2431483B1
(en)
|
2006-10-20 |
2015-04-01 |
Celera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
|
KR101398220B1
(ko)
*
|
2006-10-30 |
2014-05-22 |
건국대학교 산학협력단 |
형질전환 배아 생성방법
|
|
US20100205678A1
(en)
*
|
2007-01-05 |
2010-08-12 |
Overstrom Eric W |
Oocyte spindle-associated factors improve somatic cell cloning
|
|
KR100829426B1
(ko)
|
2007-01-17 |
2008-05-15 |
재단법인서울대학교산학협력재단 |
복제개의 생산 방법
|
|
US20080222745A1
(en)
*
|
2007-03-07 |
2008-09-11 |
Utah State University |
Colcemid-Treatment of Oocytes to enhance Nuclear Transfer Cloning
|
|
KR100868245B1
(ko)
|
2007-05-29 |
2008-11-11 |
강원대학교산학협력단 |
데메콜친 처리에 의한 효율적인 복제 동물의 생산방법
|
|
US8663980B2
(en)
|
2007-10-26 |
2014-03-04 |
Janssen Biotech, Inc. |
Vectors, host cells, and methods of production and uses
|
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
|
KR101105248B1
(ko)
|
2008-01-04 |
2012-01-17 |
재단법인서울대학교산학협력재단 |
형질전환된 복제개의 생산방법
|
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
|
US20110071049A1
(en)
|
2008-03-12 |
2011-03-24 |
Nathaniel Heintz |
Methods and compositions for translational profiling and molecular phenotyping
|
|
US8288094B2
(en)
|
2008-04-09 |
2012-10-16 |
Institut Pasteur |
APOBEC3 mediated DNA editing
|
|
US8557773B2
(en)
|
2008-05-02 |
2013-10-15 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Treatment of bleeding with low half-life fibrinogen
|
|
DK2295538T3
(en)
*
|
2008-07-07 |
2015-12-21 |
Takara Bio Inc |
Process for producing a pluripotent stem cell
|
|
EP2733222A1
(en)
|
2008-07-09 |
2014-05-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
|
|
WO2010080985A1
(en)
|
2009-01-08 |
2010-07-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
|
EP2421980A2
(en)
|
2009-04-23 |
2012-02-29 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cancer
|
|
EP2267153A1
(en)
|
2009-05-26 |
2010-12-29 |
Université Claude Bernard Lyon 1 |
Identification of netrin-1 receptor unc5c gene mutation in solid cancers
|
|
WO2011002988A1
(en)
|
2009-07-01 |
2011-01-06 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for severe combined immunodeficiency (scid)
|
|
WO2011011678A2
(en)
|
2009-07-24 |
2011-01-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cytokine-cytokine signaling pathways
|
|
WO2011014721A2
(en)
|
2009-07-30 |
2011-02-03 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pharmacokinetics
|
|
WO2011017518A2
(en)
|
2009-08-05 |
2011-02-10 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for drug metabolism
|
|
WO2011022634A2
(en)
|
2009-08-20 |
2011-02-24 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pain
|
|
US9420770B2
(en)
|
2009-12-01 |
2016-08-23 |
Indiana University Research & Technology Corporation |
Methods of modulating thrombocytopenia and modified transgenic pigs
|
|
EP2526424A2
(en)
|
2010-01-22 |
2012-11-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions,kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對ａｌｋ抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
|
NZ602634A
(en)
|
2010-03-26 |
2015-06-26 |
Dartmouth College |
Vista regulatory t cell mediator protein, vista binding agents and use thereof
|
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
|
EP2603581B1
(en)
|
2010-08-11 |
2019-07-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Cocultures of cumulus cells and embryos during in vitro fertilization procedures
|
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
|
WO2012071393A2
(en)
|
2010-11-23 |
2012-05-31 |
The New York Stem Cell Foundation |
Method for producing pluripotent stem cells
|
|
EP2675901B1
(en)
|
2011-02-14 |
2018-05-30 |
Revivicor, Inc. |
Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
|
|
WO2012129198A1
(en)
|
2011-03-23 |
2012-09-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for obesity and diabetes
|
|
LT2709445T
(lt)
|
2011-05-16 |
2018-11-12 |
The Curators Of The University Of Missouri |
Kiaulių reprodukcinio ir kvėpavimo sindromo virusui atsparūs gyvūnai
|
|
CA2848368C
(en)
|
2011-09-13 |
2023-02-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using fndc5
|
|
CN102391989A
(zh)
*
|
2011-10-12 |
2012-03-28 |
扬州大学 |
转基因动物重组产物精确分析检验方法
|
|
RS56593B1
(sr)
|
2012-02-15 |
2018-02-28 |
Novo Nordisk As |
Antitela koja vezuju i blokiraju aktivirajući receptor eksprimiran na mijeloidnim ćelijama-1 (trem-1)
|
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
|
ES2690786T3
(es)
|
2012-02-15 |
2018-11-22 |
Novo Nordisk A/S |
Anticuerpos que se unen a la proteína 1 de reconocimiento de peptidoglicano
|
|
AU2013277051B2
(en)
|
2012-06-22 |
2018-06-07 |
King's College London |
Novel VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
|
CN109793893B
(zh)
|
2012-09-07 |
2023-05-26 |
达特茅斯大学理事会 |
用于诊断和治疗癌症的vista调节剂
|
|
US20140115728A1
(en)
|
2012-10-24 |
2014-04-24 |
A. Joseph Tector |
Double knockout (gt/cmah-ko) pigs, organs and tissues
|
|
AR094778A1
(es)
|
2013-02-13 |
2015-08-26 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
Proteínas con glicosilación modificada y métodos para producirlas
|
|
AR094780A1
(es)
|
2013-02-13 |
2015-08-26 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
ANTICUERPOS ANTI-TNF-a ALTAMENTE GALACTOSILADOS Y SUS USOS
|
|
PL2993234T3
(pl)
|
2013-04-30 |
2019-04-30 |
Univ Konkuk Ind Coop Corp |
Wektor ukierunkowany na hydroksylazę kwasu cmp-acetyloneuraminowego, zwierzę transgeniczne do ksenoprzeszczepu z wprowadzonym wektorem i sposób ich wytwarzania
|
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
|
EP4043493A1
(en)
|
2013-12-24 |
2022-08-17 |
Janssen Pharmaceutica NV |
Anti-vista antibodies and fragments
|
|
US20160340407A1
(en)
|
2014-01-14 |
2016-11-24 |
Dana-Farber Camcer Institute, Inc. |
Compositions and methods for identification, assessment, prevention, and treatment of melanoma using pd-l1 isoforms
|
|
MX389695B
(es)
|
2014-06-11 |
2025-03-20 |
Kathy A Green |
Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
|
|
AU2015289054B2
(en)
|
2014-07-17 |
2021-04-08 |
Novo Nordisk A/S |
Site directed mutagenesis of trem-1 antibodies for decreasing viscosity
|
|
US10077420B2
(en)
|
2014-12-02 |
2018-09-18 |
Histogenics Corporation |
Cell and tissue culture container
|
|
MX2017007136A
(es)
|
2014-12-05 |
2017-12-04 |
Immunext Inc |
Identificacion de vsig8 como el receptor vista putativo y su uso para producir moduladores vista/vsig8.
|
|
ES2841353T3
(es)
|
2014-12-09 |
2021-07-08 |
Regeneron Pharma |
Animales no humanos que tienen un gen del grupo de diferenciación 274 humanizado
|
|
CN104823921A
(zh)
*
|
2015-05-21 |
2015-08-12 |
蒙汉勤 |
一种用于人体烧伤皮肤移植及医学实验的小型香猪的饲养技术
|
|
CA2990360C
(en)
|
2015-06-24 |
2024-02-13 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments
|
|
FR3038517B1
(fr)
|
2015-07-06 |
2020-02-28 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Utilisation de fragments fc modifies en immunotherapie
|
|
DK3331355T3
(en)
|
2015-08-06 |
2024-07-08 |
Univ Missouri |
Porcine reproductive and respiratory syndrome virus (prrsv)-resistant porcine and cells having modified cd163 genes
|
|
CA3002676A1
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
|
TWI756204B
(zh)
|
2016-02-12 |
2022-03-01 |
比利時商楊森製藥公司 |
抗ｖｉｓｔａ抗體及片段、其用途及鑑定其之方法
|
|
UA125382C2
(uk)
|
2016-04-15 |
2022-03-02 |
Імьюнекст Інк. |
Антитіла проти людського vista та їх застосування
|
|
EP3654956A4
(en)
|
2017-07-19 |
2021-04-28 |
Children's Medical Center Corporation |
COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH IMPRESSION DEFECTS
|
|
JP7699927B2
(ja)
|
2018-04-02 |
2025-06-30 |
ブリストル－マイヤーズ スクイブ カンパニー |
抗ｔｒｅｍ－１抗体およびその使用
|
|
CN112272516B
(zh)
|
2018-04-06 |
2023-05-30 |
儿童医疗中心有限公司 |
用于体细胞重新编程和调整印记的组合物和方法
|
|
US11160260B2
(en)
|
2018-04-17 |
2021-11-02 |
The Curators Of The University Of Missouri |
Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)
|
|
WO2020041360A1
(en)
|
2018-08-21 |
2020-02-27 |
Quidel Corporation |
Dbpa antibodies and uses thereof
|
|
CN115298213A
(zh)
|
2019-12-19 |
2022-11-04 |
奎多公司 |
单克隆抗体融合
|
|
JP2023551404A
(ja)
|
2020-11-20 |
2023-12-08 |
レビビコア， インコーポレイテッド |
異種間移植のための成長ホルモン受容体ノックアウトを有する多重トランスジェニックブタ
|
|
CA3232376A1
(en)
|
2021-09-20 |
2023-03-23 |
Maria KOKKINAKI |
Multitransgenic pigs comprising ten genetic modifications for xenotransplantation
|